CoQ10 in Patients with Nonalcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease is the most common cause of chronic liver injury. After 4 weeks of CoQ10 supplementation, waist circumference and serum AST concentrations were significantly decreased as compared to the placebo-treated group. The study showed a potential for CoQ10 therapy in improving serveral anthropometric and biochemical variables in non-alcoholic fatty liver disease. Longer studies…
Read More